SECsense Logo

Celanese Corporation 8-K Report: Key Insights on Stock & Debt Instruments

$CE
Form 8-K
Filed on: 2025-03-14
Source
Celanese Corporation 8-K Report: Key Insights on Stock & Debt Instruments

Based on the provided financial report excerpt, here are the key insights and information extracted:

  1. Entity Identification:
  • Company Name: Celanese Corporation
  • CIK: 0001306830
  • SEC Central Index Key: This identifier is crucial for tracking the company’s filings with the SEC.
  1. Filing Type:
  • Form Type: 8-K
  • Filing Date: March 14, 2025
  • Purpose: An 8-K form is typically used to report major events that shareholders should know about.
  1. Common Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.0001 per share
  • Stock Exchange: NYSE (New York Stock Exchange)
  • Ticker Symbol: CE
  1. Debt Instruments:
  • The company has issued several senior notes, which are debt securities. The relevant details are as follows:
    • 4.777% Senior Notes Due 2026 (Ticker: CE/26A)
    • 2.125% Senior Notes Due 2027 (Ticker: CE/27)
    • 0.625% Senior Notes Due 2028 (Ticker: CE/28)
    • 5.337% Senior Notes Due 2029 (Ticker: CE/29A)
  1. Locations:
  • Headquarters: 222 West Las Colinas Blvd., Suite 900N, Irving, TX 75039
  • Contact Number: 972-443-4000
  1. Financial Reporting Context:
  • The report includes several segments related to stock classifications, specifically mentioning different classes of senior unsecured notes with various due dates (2026-2029).
  • Each class of stock and notes is explicitly identified in the report, which is helpful for investors looking to understand the capital structure and the maturity profile of the company's debt.
  1. Regulatory Compliance:
  • The presence of XBRL (eXtensible Business Reporting Language) tags indicates that the filing is structured for automated extraction of financial data, enhancing transparency and accessibility for investors and analysts.

In summary, this report provides an overview of Celanese Corporation's stock and debt instruments, essential for potential investors or stakeholders analyzing the company's financial health and capital structure as of March 14, 2025.